What a drag!: Skeletal myosin binding protein-C affects sarcomeric shortening.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Chronic and acute mediators of passive viscoelasticity in human skeletal muscle fibres.Experimental physiology · 2025
   Article
2. Modulation of striated-muscle contractility by a high-affinity myosin-targeting peptide.Biophysical journal · 2025
   Article
3. Nanosurfer assay dissects β-cardiac myosin and cardiac myosin-binding protein C interactions.Biophysical journal · 2022
   Article
4. Progress on the regulation of myofibrillar function: Part 2.The Journal of general physiology · 2019
   Article

Corrections and comments

• Comment on
  Regulation of myofilament force and loaded shortening by skeletal myosin binding protein C.2019

Authors and funding

1 author.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as